UBE3A stabilization of β-catenin preserves synaptic proteins essential for motor and cognitive functions in Angelman Syndrome
Open Access
- 27 November 2025
- journal article
- research article
- Published by Springer Nature in Molecular Autism
- Vol. 16 (1) , 60
Abstract
Ubiquitin protein ligase E3A (UBE3A) regulates signaling pathways associated with autism spectrum disorders (ASDs). As an E3 ligase, UBE3A ubiquitinates anKeywords
Funding Information
- Foundation for Angelman Syndrome Therapeutics (PD2023-001, FT2024-001, FT2022-005)
This publication has 116 references indexed in Scilit:
- Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In VivoDiabetes, 2003
- Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrilsMolecular Psychiatry, 2003
- Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicityNeuropharmacology, 2002
- BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agentsJournal of Neurochemistry, 2002
- Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brainPsychopharmacology, 2001
- Activation of Synaptic NMDA Receptors Induces Membrane Insertion of New AMPA Receptors and LTP in Cultured Hippocampal NeuronsNeuron, 2001
- Signaling Mechanisms Mediating BDNF Modulation of Synaptic Plasticity in the HippocampusLearning & Memory, 1999
- Mutation of the Angelman Ubiquitin Ligase in Mice Causes Increased Cytoplasmic p53 and Deficits of Contextual Learning and Long-Term PotentiationNeuron, 1998
- De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndromeNature Genetics, 1997
- UBE3A/E6-AP mutations cause Angelman syndromeNature Genetics, 1997